Package 0031-2097-01

{"route": ["ORAL"], "spl_id": "446ee4e3-9b08-b5a1-e063-6394a90a0a4e", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "unii": ["9D2RTI9KYH", "495W7451VQ"], "rxcui": ["1020138"], "spl_set_id": ["d13efbcd-1277-45d0-8389-1ba0337f7a24"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["Haleon US Holdings LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (0031-2097-01)  / 118 mL in 1 BOTTLE", "package_ndc": "0031-2097-01", "marketing_start_date": "20210614"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (0031-2097-02)  / 237 mL in 1 BOTTLE", "package_ndc": "0031-2097-02", "marketing_start_date": "20210614"}], "brand_name": "Robitussin Elderberry Maximum Strength Cough plus Chest Congestion DM", "product_id": "0031-2097_446ee4e3-9b08-b5a1-e063-6394a90a0a4e", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "Sigma-1 Agonist [EPC]", "Sigma-1 Receptor Agonists [MoA]", "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]", "Uncompetitive NMDA Receptor Antagonists [MoA]"], "product_ndc": "0031-2097", "generic_name": "dextromethorphan HBr, guaifenesin", "labeler_name": "Haleon US Holdings LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Robitussin Elderberry Maximum Strength Cough plus Chest Congestion DM", "active_ingredients": [{"name": "DEXTROMETHORPHAN HYDROBROMIDE", "strength": "20 mg/20mL"}, {"name": "GUAIFENESIN", "strength": "400 mg/20mL"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20210614", "listing_expiration_date": "20261231"}